Treatment of severe covid-19 with interleukin 6 receptor inhibition
Skanda Rajasundaram, Stephen Burgess, Dipender Gill
Abstract
> Tocilizumab and sarilumab only offer benefit in severe covid-19 when combined with corticosteroids The use of tocilizumab or sarilumab in combination with corticosteroids has been an important development in the treatment of severe covid-19. In contrast to monoclonal antibody treatments that
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)Medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Monoclonal antibodyVirologyMonoclonalInternal medicineImmunologyAntibodyOutbreakDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research